Acumen Pharmaceuticals   Report issue

For profit Phase 1 Phase 2
Founded: Livermore CA United States (1996)
Status: Left NME R&D (2004)

Organization Overview

First Clinical Trial
2008
NCT00702221
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Acumen Pharmaceuticals | Acumen Pharmaceuticals, Inc. | The Acumen Pharmaceuticals Services Ltd